Days in A/R: What It Means, a Good Benchmark & How to Cut It

Days in A/R — days in accounts receivable — is how long, on average, your practice waits to get paid after it bills. The math is simple: total accounts receivable ÷ average daily charges. A well-run practice keeps it around 30–40 days, and under 50 at the very least (AAFP, HFMA). But be honest about that number: it's a professional guideline, not a measured national average — real figures vary by specialty and payer, and they've been rising. So the benchmark tells you the neighborhood; your own trend line is the real score.

This guide covers exactly what days in A/R measures, how to calculate it (and the gross-vs-net trap that makes two practices disagree), what a good number really is, the separate aging metric everyone conflates with it, and the levers that actually bring it down.

What days in A/R actually measures

Accounts receivable is money you've earned but haven't collected — claims out with payers, balances out with patients. Days in A/R converts that pile into a single, comparable number: if you stopped billing today, how many days of charges are still sitting unpaid? Lower is faster cash; a rising number is billing falling behind, weeks before you feel it in the bank.

The one subtlety that trips people up is the denominator. AAFP defines average daily charges on your charges net of credits, over a period you choose — "three months, six months, 12 months." HFMA's hospital-oriented version instead divides net A/R by average daily net revenue. Same idea, different denominator — which is precisely why two practices "measuring the same thing" land on different numbers. Pick one definition, write it down, and use it consistently; the comparison that matters is against your own prior quarters, not someone else's spreadsheet.

What's a good days in A/R?

Here the guidance is unusually consistent. AAFP puts it plainly: days in A/R "should stay below 50 days at minimum; however, 30 to 40 days is preferable." HFMA's revenue-cycle primer lands in the same place — net days in A/R "ideally should range between 30–40 days." When the two main authorities converge, that's a target worth trusting.

Two honesty flags, because the vendor blogs skip them. First, 30–40 is a guideline, not a study — it's a professional rule of thumb, not a measured average, so don't quote it as "the industry average." Second, the real numbers are a moving target: across a dataset of 2,100+ hospitals and roughly 300,000 physicians, measured A/R days grew 5.2% year over year in 2024 (Kodiak Solutions), alongside rising denials. And the tidy "MGMA median = X days" figures circulating online aren't verifiable — MGMA's absolute medians live behind the paid DataDive; only relative figures are public. Treat 30–40 as your target and your own trend as the verdict.

Days in A/R vs. "A/R over 90 days" — not the same number

These get used interchangeably, and they're different metrics. Days in A/R is the average speed of your whole receivables pile. A/R over 90 days is an aging metric — the share of what you're owed that's been sitting past 90 days, and it's the one that predicts write-offs, because collectibility drops the longer a balance ages.

The healthy threshold depends on who you ask: AAFP's long-standing rule is under 15% of A/R over 90 days; HFMA sets a tighter under 10%. Either way, the top performers barely carry aged balances at all — MGMA's "better performers" keep over 70% of their A/R under 30 days and just 8.1% past 120 days. Watch both numbers: a healthy average can still hide an ugly tail of old claims nobody's working.

Why days in A/R is worth watching

It's an early-warning gauge, and it doesn't drift alone. Days in A/R sits at the end of a chain that starts with clean claims and denials — it's the outcome of your revenue cycle, not an isolated stat. When it climbs, look upstream: initial claim denials rose to 11.81% in 2024, and A/R days rose right alongside them (Kodiak). A denial you don't rework fast becomes an aged balance, which becomes a write-off.

The other pressure is coming from patients. As high-deductible plans spread, more of every bill lands on the patient — the average single-coverage deductible hit $1,787 in 2024 (KFF), and patient balances are the hardest kind to collect: providers recovered just 34.46% of what insured patients owed in 2024, down from 37.58% the year before (Kodiak). That uncollected patient portion doesn't vanish — it ages inside your A/R and drags the number up a day at a time. Days in A/R is where all of that becomes visible.

How to cut your days in A/R

You can't shorten what you don't watch

Most practices can quote their revenue but not how many days of it are sitting unpaid right now — or which payer and which age bucket are dragging the number up. Put days in A/R on the dashboard next to your aging buckets, tracked against your own prior quarters, and a billing slowdown stops being a cash-flow surprise and becomes a worklist. It's one of the 12 KPIs every practice should track, and it's inseparable from the net collection rate that decides how much of that A/R you ultimately keep.

Frequently asked questions

Written by

Olha · clinic data analyst

I build the reporting our managers open every morning at a multi-branch medical clinic — and package it so other practices don't have to start from scratch.

The 30–40 day and over-90-day figures are AAFP and HFMA professional guidance rather than a single study; measured-trend figures are from Kodiak Solutions' 2024 dataset, deductibles from KFF, and electronic-transaction figures per the 2024 CAQH Index. Lucid Vitals is not affiliated with Microsoft.